Literature DB >> 2844348

Haemolytic uraemic syndrome after bone marrow transplantation: an adverse effect of total body irradiation?

M E Chappell1, D M Keeling, H G Prentice, P Sweny.   

Abstract

Eight cases of haemolytic uraemic syndrome occurring after bone marrow transplantation are presented and the other 15 reported cases are reviewed. Two patients were recipients of autologous marrow whereas all cases previously reported occurred after allogeneic transplantation. Six patients had not received cyclosporin and two had no evidence of cytomegalovirus infection. The roles of cyclosporin, cytomegalovirus infection, graft-versus-host disease, total body irradiation (TBI) and chemotherapeutic drugs as aetiological agents are discussed. It is postulated that TBI, perhaps potentiated by cyclophosphamide, is likely to be the most important factor but that other agents may act additively with TBI and influence the time course and severity of the disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844348

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  12 in total

1.  Clinical significance of fragmented red cells after allogeneic bone marrow transplantation.

Authors:  Heiwa Kanamori; Yumiko Takaishi; Maki Takabayashi; Masatsugu Tanaka; Satoshi Yamaji; Naoto Tomita; Katsumichi Fujimaki; Shin Fujisawa; Shinichiro Watanabe; Michio Matsuzaki; Yoshiaki Ishigatsubo
Journal:  Int J Hematol       Date:  2003-02       Impact factor: 2.490

Review 2.  Kidney transplantation for treatment of end-stage kidney disease after haematopoietic stem cell transplantation: case series and literature review.

Authors:  Akihiro Tsuchimoto; Kosuke Masutani; Kazuya Omoto; Masayoshi Okumi; Yasuhiro Okabe; Takehiro Nishiki; Morihito Ota; Toshiaki Nakano; Kazuhiko Tsuruya; Takanari Kitazono; Masafumi Nakamura; Hideki Ishida; Kazunari Tanabe
Journal:  Clin Exp Nephrol       Date:  2018-12-24       Impact factor: 2.801

Review 3.  The pathophysiology of Sandimmune (cyclosporine) in man and animals.

Authors:  J Mason
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

4.  Renal thrombotic microangiopathy after hematopoietic cell transplant: role of GVHD in pathogenesis.

Authors:  Siribha Changsirikulchai; David Myerson; Katherine A Guthrie; George B McDonald; Charles E Alpers; Sangeeta R Hingorani
Journal:  Clin J Am Soc Nephrol       Date:  2009-01-14       Impact factor: 8.237

5.  Incidence and predictors of delayed chronic kidney disease in long-term survivors of hematopoietic cell transplantation.

Authors:  Michael Choi; Can-Lan Sun; Seira Kurian; Andrea Carter; Liton Francisco; Stephen J Forman; Smita Bhatia
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

6.  Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.

Authors:  Eric P Cohen; Amy A Irving; William R Drobyski; John P Klein; Jakob Passweg; Julie-An M Talano; Mark B Juckett; John E Moulder
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-10-29       Impact factor: 7.038

Review 7.  Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment.

Authors:  Cecilia M Choi; Alvin H Schmaier; Michael R Snell; Hillard M Lazarus
Journal:  Drugs       Date:  2009       Impact factor: 9.546

8.  Thrombotic microangiopathy in haematopoietic cell transplantation: an update.

Authors:  Evi Stavrou; Hillard M Lazarus
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-11-03       Impact factor: 2.576

Review 9.  Clinical review: specific aspects of acute renal failure in cancer patients.

Authors:  Michael Darmon; Magali Ciroldi; Guillaume Thiery; Benoît Schlemmer; Elie Azoulay
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 10.  Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19.

Authors:  Marcel Levi
Journal:  Hemasphere       Date:  2021-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.